
About
This app provides a comprehensive online supply chain service platform for medical device distributors and healthcare institutions. It offers a wide selection of products from leading brands at competitive prices, along with business opportunities and industry insights.
What's New in 贝登医疗
2.9.3
April 16, 2026
优化部分细节问题
Developer apps
FAQ
What is 贝登医疗?
贝登医疗 is an app that offers a one-stop supply chain service platform for medical device distributors and healthcare institutions. It connects upstream and downstream partners through online, digital, and intelligent transactions.
What brands are available on 贝登医疗?
贝登医疗 has exclusive authorized cooperation with over 200 domestic and international renowned brands, including Mindray, GE, Schiller, and 3M. The platform features over 1000 strategic brand partnerships and a selection of over 50,000 products.
Does 贝登医疗 offer discounts or promotions?
Yes, 贝登医疗 frequently features brand-specific events, special price promotions, and offers on popular items. New customers may also receive coupons, such as a 1000 yuan voucher.
How does 贝登医疗 help with business opportunities?
The app includes a tender center with daily updated national tender information, providing numerous business opportunities. It also offers industry policy interpretations and a 'Distributor Academy' to help users solve sales problems.
What kind of services does 贝登医疗 provide beyond product sales?
贝登医疗 offers comprehensive medical device services, including nationwide warehousing and distribution, as well as after-sales repair, to enhance efficiency and user experience.
Is 贝登医疗 available on multiple devices?
Based on the provided data, 贝登医疗 is supported on iPhones and iPods. It is not specified if it is available on Android devices.
How often is 贝登医疗 updated?
The latest version of 贝登医疗 is 2.9.3, and it was last updated on April 16, 2026. This indicates a proactive development cycle for the application.
What is the user rating for 贝登医疗?
贝登医疗 has a high user rating of 5.0 stars based on 1 review. This suggests a very positive reception from its current user base.





